Pharmacotherapy for Type 2 Diabetes Mellitus: What's Up and Coming in the Glucagon-Like Peptide-1 (GLP-1) Pipeline?

MLA

Elder, Mary J., and Emily J. Ashjian. “Pharmacotherapy for Type 2 Diabetes Mellitus: What’s Up and Coming in the Glucagon-Like Peptide-1 (GLP-1) Pipeline?” Journal of Pharmacy Practice, vol. 36, no. 2, Apr. 2023, pp. 418–28. EBSCOhost, https://doi.org/10.1177/08971900211049032.

APA

Elder, M. J., & Ashjian, E. J. (2023). Pharmacotherapy for Type 2 Diabetes Mellitus: What’s Up and Coming in the Glucagon-Like Peptide-1 (GLP-1) Pipeline? Journal of Pharmacy Practice, 36(2), 418–428. https://doi.org/10.1177/08971900211049032

Chicago

Elder, Mary J, and Emily J Ashjian. 2023. “Pharmacotherapy for Type 2 Diabetes Mellitus: What’s Up and Coming in the Glucagon-Like Peptide-1 (GLP-1) Pipeline?” Journal of Pharmacy Practice 36 (2): 418–28. doi:10.1177/08971900211049032.